A. L. Daragon, ostéoporose : une vieille maladie? encore toute jeune, Kinesither rev, issue.123, pp.1-2, 2012.
DOI : 10.1016/s1779-0123(12)75275-0

S. Cummings and L. Melton, Epidemiology and outcomes of osteoporotic fractures, The Lancet, vol.359, issue.9319, pp.1761-1768, 2002.
DOI : 10.1016/S0140-6736(02)08657-9

O. Johnell and J. Kanis, Epidemiology of osteoporotic fractures, Osteoporosis International, vol.15, issue.S02, pp.3-7, 2005.
DOI : 10.1007/s00198-004-1702-6

S. Kolta, J. Fechtenbaum, and C. Roux, La densitométrie osseuse. Paris : Médecine-Sciences Flammarion, 2005.

C. Haouichat, Place de??l'ost??odensitom??trie ????ultrason dans??le??d??pistage de??l'ost??oporose post m??nopausique, Revue du Rhumatisme, vol.74, issue.10-11, pp.1039-1208, 2007.
DOI : 10.1016/j.rhum.2007.10.186

P. Gardsell, O. Johnell, and B. Nilsson, The predictive value of bone loss for fragility fractures in women: A longitudinal study over 15 years, Calcified Tissue International, vol.4, issue.Suppl 1, pp.90-94, 1991.
DOI : 10.1007/BF02565127

D. Black, S. Cummings, and H. Genant, Axial and appendicular bone density predict fractures in older women, Journal of Bone and Mineral Research, vol.82, issue.Suppl 1B, pp.633-641, 1992.
DOI : 10.1002/jbmr.5650070607

S. Cummings, D. Black, and M. Newitt, Bone density at various sites for prediction of hip fractures, The Lancet, vol.341, issue.8837, pp.72-77, 1993.
DOI : 10.1016/0140-6736(93)92555-8

H. Autorité-de-santé-lewiecki, E. Watts, N. Mcclung, and M. , Ostéodensitométrie sur 2 sites par méthode bi photonique. 2006. www.hassante.fr [14] World Health Organization (WHO) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group. WHO technical report series n 843 Official position of the International society for clinical densitometry, WHO J Clin Endocrinol Metab, vol.89, pp.1-293651, 1994.

K. Briot, 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis, Joint Bone Spine, vol.79, issue.3, pp.304-317, 2012.
DOI : 10.1016/j.jbspin.2012.02.014

O. Johnell and J. Kanis, An estimate of the worldwide prevalence and disability associated with osteoporotic fractures, Osteoporosis International, vol.16, issue.suppl 2, pp.1726-1759, 2006.
DOI : 10.1007/s00198-006-0172-4

M. Maravic, L. Bihan, C. Landais, and P. , Incidence and cost of osteoporotic fractures in France during 2001. A methodological approach by the national hospital database, Osteoporosis International, vol.13, issue.12, pp.1475-80, 2005.
DOI : 10.1007/s00198-005-2031-0

D. Curran, Epidemiology of osteoporosis-related fractures in France: A literature review, Joint Bone Spine, vol.77, issue.6, pp.546-51, 2010.
DOI : 10.1016/j.jbspin.2010.02.006

I. Melton, . Lj, and S. Cummings, Heterogeneity of age-related fractures : Implications for epidemiology, Bone Min, vol.2, pp.321-331, 1987.

C. Baudoin, P. Fardellone, and B. Thelot, Hip fractures in France: The magnitude and perspective of the problem, Osteoporosis International, vol.75, issue.Suppl 2, pp.1-10, 1996.
DOI : 10.1007/BF01623756

C. Baudoin, The cost of osteoporosis in France, Rev Rhum Engl Ed, vol.64, pp.441-443, 1997.

J. Magaziner, E. Simonsick, T. Kashner, J. Hebel, and J. Kenzora, Survival experience of aged hip fracture patients., American Journal of Public Health, vol.79, issue.3, pp.274-282, 1989.
DOI : 10.2105/AJPH.79.3.274

P. Chassagne, L. Druesne, C. Bentot, and N. Kadri, La confusion mentale chez les sujets ??g??s, La Presse M??dicale, vol.34, issue.12, pp.863-871, 2005.
DOI : 10.1016/S0755-4982(05)84066-7

C. Cooper, E. Atkinson, O. Fallon, W. Melton, and L. , Incidence of clinically diagnosed vertebral fractures: a population-based study in, pp.1985-1989, 1992.

F. Grados, C. Marcelli, and P. Dargent-molina, Prevalence of vertebral fractures in French women older than 75 years from the EPIDOS study, Bone, vol.34, issue.2, pp.362-369, 2004.
DOI : 10.1016/j.bone.2003.11.008

C. Cooper, E. Atkinson, S. Jacobsen, O. Fallon, W. Melton et al., Population-Based Study of Survival after Osteoporotic Fractures, American Journal of Epidemiology, vol.137, issue.9, pp.1001-1005, 1993.
DOI : 10.1093/oxfordjournals.aje.a116756

S. Cummings, J. Kelsey, M. Nevitt, and O. Dowd, EPIDEMIOLOGY OF OSTEOPOROSIS AND OSTEOPOROTIC FRACTURES, Epidemiologic Reviews, vol.7, issue.1, pp.178-208, 1985.
DOI : 10.1093/oxfordjournals.epirev.a036281

S. Cummings and M. Nevitt, A Hypothesis: The Causes of Hip Fractures, Journal of Gerontology, vol.44, issue.5, pp.107-118, 1989.
DOI : 10.1093/geronj/44.5.M107

A. Stevens, J. Lowe, and H. Histology, Times Mirror International Publishers Limited, 1997.

T. Rachner, S. Khosla, and C. Hofbauer, Osteoporosis: now and the future, The Lancet, vol.377, issue.9773, pp.1276-87, 2011.
DOI : 10.1016/S0140-6736(10)62349-5

M. Quemerais-durieu, V. Kerlan, and O. Chabre, Innovations th??rapeutiques dans l???ost??oporose (anticorps antiscl??rostine et denosumab), Annales d'Endocrinologie, vol.72, issue.1, pp.15-22, 2011.
DOI : 10.1016/S0003-4266(11)70005-1

S. Roux, New treatment targets in osteoporosis, Joint Bone Spine, vol.77, issue.3, pp.222-230, 2010.
DOI : 10.1016/j.jbspin.2010.02.004

S. Judes, R. Garman, M. Squire, L. Donahue, and C. Rubin, Genetically Based Influences on the Site-Specific Regulation of Trabecular and Cortical Bone Morphology, Journal of Bone and Mineral Research, vol.11, issue.4, pp.600-606, 2004.
DOI : 10.1359/JBMR.040101

S. Cusak and K. Cashman, Impact of genetic variation on metabolic response of bone to diet, Proceedings of the Nutrition Society, vol.60, issue.04, pp.901-913, 2003.
DOI : 10.1002/jbmr.5650110304

R. Pacifici, Estrogen, cytokines, and pathogenesis of postmenopausal osteoporosis, Journal of Bone and Mineral Research, vol.10, issue.Suppl 1, pp.1043-51, 1996.
DOI : 10.1002/jbmr.5650110802

E. Siris, Y. Chen, and T. Abbott, Bone Mineral Density Thresholds for Pharmacological Intervention to Prevent Fractures, Archives of Internal Medicine, vol.164, issue.10, pp.1108-1120, 2004.
DOI : 10.1001/archinte.164.10.1108

E. Lespessailles, C. Gadois, and I. Kousignan, Clinical interest of bone texture analysis in osteoporosis: a case control multicenter study, Osteoporosis International, vol.6, issue.Suppl 1, pp.1019-1047, 2008.
DOI : 10.1007/s00198-007-0532-8

E. Sornay-rendu, S. Boutroy, and F. Munoz, Alterations of Cortical and Trabecular Architecture Are Associated With Fractures in Postmenopausal Women, Partially Independent of Decreased BMD Measured by DXA: The OFELY Study, Journal of Bone and Mineral Research, vol.312, issue.3, pp.425-458, 2007.
DOI : 10.1359/jbmr.061206

D. Black, N. Arden, and L. Palermo, Prevalent vertebral deformities predict hip fractures and new vertebral deformities but nop wrist fractures, J Bone Miner Res, vol.5, pp.821-829, 1999.

J. Kanis, O. Johnell, D. Laet, C. Johansson, H. Oden et al., A meta-analysis of previous fracture and subsequent fracture risk, Bone, vol.35, issue.2, pp.375-82, 2004.
DOI : 10.1016/j.bone.2004.03.024

D. Marshall, O. Johnell, and H. Wedel, 96153999 Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures, Maturitas, vol.25, issue.2, pp.1254-1259, 1996.
DOI : 10.1016/0378-5122(96)81789-0

P. Dargent-molina and G. Breart, Epidémiologie des chutes et des traumatismes lies aux chutes chez les personnes âgées, Rev Epidemiol Sante Publique, vol.43, pp.72-83, 1995.

P. Dargent-molina, F. Favier, H. Grandjean, C. Baudoin, and A. Schott, Fall-related factors and risk of hip fracture: the EPIDOS prospective study, The Lancet, vol.348, issue.9021, pp.145-154, 1996.
DOI : 10.1016/S0140-6736(96)01440-7

D. Briançon, J. De-gaudemar, and R. Forestier, Management of osteoporosis in women with peripheral osteoporotic fractures after 50 years of age: a study of practices, Joint Bone Spine, vol.71, issue.2, pp.128-158, 2004.
DOI : 10.1016/S1297-319X(03)00060-5

E. Lespessailles, F. Cotté, C. Roux, P. Fardellone, F. Mercier et al., Prevalence and features of osteoporosis in the French general population: The Instant study, Joint Bone Spine, vol.76, issue.4, pp.394-400, 2009.
DOI : 10.1016/j.jbspin.2008.10.008

A. Fontana and P. Delmas, L???ost??oporose : ??pid??miologie, clinique et approches th??rapeutiques, m??decine/sciences, vol.17, issue.12, pp.1297-1305, 2001.
DOI : 10.1051/medsci/200117121297

J. Pouillès, F. Trémollières, and C. Ribot, Osteoporosis in otherwise healthy perimenopausal and early postmenopausal women: Physical and biochemical characteristics, Osteoporosis International, vol.68, issue.2, pp.193-200, 2006.
DOI : 10.1007/s00198-005-1954-9

C. Frayssinet and F. Trémollières, Ost??oporose postm??nopausique??: quand faut-il demander un bilan biologique??? En quoi consiste-t-il???, Gyn??cologie Obst??trique & Fertilit??, vol.36, issue.6, pp.656-658, 2008.
DOI : 10.1016/j.gyobfe.2008.04.005

E. Legrand, B. Bouvard, E. Hoppé, and M. Audran, Ost??oporoses??: g??n??ralit??s, strat??gie diagnostique, EMC - Appareil locomoteur, vol.7, issue.2, pp.1-5, 2012.
DOI : 10.1016/S0246-0521(12)51756-0

A. Daragon and O. Vittecoq, Osteoporosis in the elderly. Practical prevention and treatment

N. Barro-belaygues, Prevention of nonvertebral fractures with oral vitamin D and dose dependency a meta-analysis of randomized controlled trials, Les cahiers de l'ann??e g??rontologique, vol.340, issue.3, pp.209-211, 2010.
DOI : 10.1007/s12612-010-0061-5

A. Jung, S. Bisaz, and H. Fleisch, The binding of pyrophosphate and two diphosphonates by hydroxyapatite crystals, Calcified Tissue Research, vol.74, issue.Suppl., pp.269-280, 1973.
DOI : 10.1007/BF02547227

A. Naveau and B. Naveau, Osteonecrosis of??the??jaw in??patients taking bisphosphonates, Joint Bone Spine, vol.73, issue.1, p.7, 2006.
DOI : 10.1016/j.jbspin.2005.11.002

M. Audran, B. Cortet, and T. Thomas, What do we know about atypical femoral fractures? Insights and enigmas Joint Bone Spine, pp.568-571, 2011.

D. Black, S. Cummings, and D. Karpf, Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures, The Lancet, vol.348, issue.9041, pp.1535-1576, 1996.
DOI : 10.1016/S0140-6736(96)07088-2

S. Cummings, D. Black, and D. Thompson, Effect of Alendronate on Risk of Fracture in Women With Low Bone Density but Without Vertebral Fractures<SUBTITLE>Results From the Fracture Intervention Trial</SUBTITLE>, JAMA, vol.280, issue.24, pp.2077-82, 1998.
DOI : 10.1001/jama.280.24.2077

H. Bone, D. Hosking, and J. Devogelaer, Ten Years' Experience with Alendronate for Osteoporosis in Postmenopausal Women, New England Journal of Medicine, vol.350, issue.12, pp.1189-99, 2004.
DOI : 10.1056/NEJMoa030897

S. Harris, N. Watts, and H. Genant, Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>, JAMA, vol.282, issue.14, pp.1344-52, 1999.
DOI : 10.1001/jama.282.14.1344

J. Reginster, H. Minne, and O. Sorensen, Randomized Trial of the Effects of Risedronate on Vertebral Fractures in Women with Established Postmenopausal Osteoporosis, Osteoporosis International, vol.11, issue.1
DOI : 10.1007/s001980050010

D. Mellstrom, O. Sorensen, and S. Goemaere, Seven Years of Treatment with Risedronate in Women with Postmenopausal Osteoporosis, Calcified Tissue International, vol.6, issue.S1, pp.462-470, 2004.
DOI : 10.1007/s001980070004

D. Black, P. Delmas, and R. Eastell, Once-Yearly Zoledronic Acid for Treatment of Postmenopausal Osteoporosis, New England Journal of Medicine, vol.356, issue.18, pp.1809-1831, 2007.
DOI : 10.1056/NEJMoa067312

D. Black, I. Reid, and S. Boonen, The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT), J Bone Miner Res, 2011.

C. Cooper, R. Emkey, and R. Mcdonald, Efficacy and Safety of Oral Weekly Ibandronate in the Treatment of Postmenopausal Osteoporosis, The Journal of Clinical Endocrinology & Metabolism, vol.88, issue.10, pp.4609-4624, 2003.
DOI : 10.1210/jc.2003-022029

N. Watts, S. Harris, and H. Genant, Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis, New England Journal of Medicine, vol.323, issue.2, pp.73-82, 1990.
DOI : 10.1056/NEJM199007123230201

R. Levasseur, J. Sabatier, and C. Marcelli, Physiopathologie de l'ost??oporose, La Revue de M??decine Interne, vol.25, pp.531-537, 2004.
DOI : 10.1016/S0248-8663(04)80051-1

S. Cummings, S. Martin, J. Mcclung, and M. , Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis, New England Journal of Medicine, vol.361, issue.8, pp.756-65, 2009.
DOI : 10.1056/NEJMoa0809493

B. Ettinger, D. Black, and B. Mitlakj, Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene<SUBTITLE>Results From a 3-Year Randomized Clinical Trial</SUBTITLE>, JAMA, vol.282, issue.7, pp.637-682, 1999.
DOI : 10.1001/jama.282.7.637

S. Martino, J. Cauley, and E. Barrett-connor, Continuing Outcomes Relevant to Evista: Breast Cancer Incidence in Postmenopausal Osteoporotic Women in a Randomized Trial of Raloxifene, JNCI Journal of the National Cancer Institute, vol.96, issue.23, pp.1751-61, 2004.
DOI : 10.1093/jnci/djh319

J. Reginster, E. Seeman, D. Vernejoul, and M. , Strontium Ranelate Reduces the Risk of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.5, pp.2816-2838, 2005.
DOI : 10.1210/jc.2004-1774

J. Reginster, J. Kaufman, and S. Goemaere, Maintenance of antifracture efficacy over 10??years with strontium ranelate in postmenopausal osteoporosis, Osteoporosis International, vol.29, issue.suppl 1, pp.1115-1137, 2012.
DOI : 10.1007/s00198-011-1847-z

R. Neer, C. Arnaud, and J. Zanchetta, Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis, New England Journal of Medicine, vol.344, issue.19, pp.1434-1475, 2001.
DOI : 10.1056/NEJM200105103441904

A. Lobersztajn, F. Trémollières, . Ménopause, and . Bone, M??nopause et os, Journal de Gyn??cologie Obst??trique et Biologie de la Reproduction, vol.41, issue.7, pp.28-32, 2012.
DOI : 10.1016/j.jgyn.2012.09.005

G. Wells, V. Meta-Analysis of the Efficacy of Hormone Replacement Therapy in Treating and Preventing Osteoporosis in Postmenopausal Women, Endocrine Reviews, vol.23, issue.4, pp.529-568, 2002.
DOI : 10.1210/er.2001-5002

URL : https://hal.archives-ouvertes.fr/hal-00677117

D. Bliuc, N. Nguyen, and V. Milch, Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women, JAMA, vol.301, issue.5, pp.513-534, 2009.
DOI : 10.1001/jama.2009.50

P. Haentjens, J. Magaziner, and C. Colón-emeric, Meta-analysis: Excess Mortality After Hip Fracture Among Older Women and Men, Annals of Internal Medicine, vol.152, issue.6, pp.380-90, 2010.
DOI : 10.7326/0003-4819-152-6-201003160-00008

J. Kanis, O. Johnell, and A. Oden, FRAX??? and the assessment of fracture probability in men and women from the UK, Osteoporosis International, vol.17, issue.Suppl 2, pp.385-97, 2008.
DOI : 10.1007/s00198-007-0543-5

C. Roux and T. Thomas, Optimal use of FRAX??, Joint Bone Spine, vol.76, issue.1, pp.1-3, 2009.
DOI : 10.1016/j.jbspin.2008.11.001

URL : https://hal.archives-ouvertes.fr/inserm-00395611

B. Abrahamsem, P. Vestergaard, and B. Rud, Ten-year absolute risk of osteoporotic fractures according to BMD T score at menopause: the Danish osteoporosis prevention study

F. Trémollieres, T. Cochet, C. Cohade, J. Pouillès, and C. Ribot, Fracture risk in early postmenopausal women assessed using FRAX??, Joint Bone Spine, vol.77, issue.4, pp.345-348, 2010.
DOI : 10.1016/j.jbspin.2010.04.012

E. Sornay-rendu, F. Munoz, and P. Delmas, The FRAX tool in French women: How well does it describe the real incidence of fracture in the OFELY cohort, Journal of Bone and Mineral Research, vol.21, issue.10, pp.2-101, 2010.
DOI : 10.1002/jbmr.106

R. Chapurlat, Contribution and limitations of the FRAX?? tool, Joint Bone Spine, vol.80, issue.4, pp.355-357, 2013.
DOI : 10.1016/j.jbspin.2013.03.001

K. Briot, Sequential osteoporosis treatments, Joint Bone Spine, vol.78, issue.6, pp.545-549, 2011.
DOI : 10.1016/j.jbspin.2011.09.014

E. Legrand, ?? propos des nouvelles recommandations sur le traitement de l???ost??oporose post-m??nopausique, Revue du Rhumatisme, vol.79, issue.3, pp.191-193, 2012.
DOI : 10.1016/j.rhum.2012.04.002

L. Druesne, M. Tabue, L. Quibel, and P. Chassagne, Place d'une équipe mobile de gériatrie dans un service de chirurgie. Soins Gérontologie -n°87 ? janvier, pp.39-41

T. Ait-abdesselam, A. Lamacz, S. Titz, G. Micaud, N. Biga et al., Pr??vention secondaire de??l'ost??oporose fracturaire: r??sultats ????un??an d'une fili??re de??prise en??charge des??patients fractur??s, Revue du Rhumatisme, vol.73, issue.10-11, p.1140, 2006.
DOI : 10.1016/j.rhum.2006.10.315